In the CY 2026 OPPS/ASC proposed rule we stated that the burden was minimized because the median payer-specific negotiated charge data that we proposed to collect on the Supplemental to Form CMS-2552-10: Weighted Median MAO Payer-Specific Negotiated Charge Data Worksheet is based on payer-specific data that would already be maintained by the hospital, the data from the MRF that hospitals are required to disclose under the hospital price transparency regulations at 45 CFR part 180
Patients with hypothyroidism should proactively share their current thyroid medication, TSH target range, and recent lab results so the PlexusDx team can coordinate care with their existing providers
We also like that it comes in different strengths, so you can find the one that's right for you
Change in mean bodyweight was -9.6% with semaglutide 2.4 mg vs
For patients whose insurance denies coverage entirely, the difference between $3,000 annually through PlexusDx versus paying full retail price ($8,000$12,000) for brand Zepbound represents substantial savings
